US Stock MarketDetailed Quotes

MXCT MaxCyte

Watchlist
  • 3.950
  • +0.070+1.80%
Close Apr 19 16:00 ET
  • 3.950
  • 0.0000.00%
Post 16:03 ET
411.31MMarket Cap-10675P/E (TTM)

About MaxCyte Company

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.

Company Profile

SymbolMXCT
Company NameMaxCyte
Listing DateJul 30, 2021
Issue Price13.00
Founded1998
CEOMr. Maher Masoud
MarketNASDAQ
Employees143
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9713 Key West Avenue,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-944-1700
Websitehttp://www.maxcyte.com

Company Executives

  • Name
  • Position
  • Salary
  • Maher Masoud
  • President, Chief Executive Officer and Director
  • 790.87K
  • Douglas J Swirsky
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Thomas M. Ross
  • Executive Vice President, Global Sales
  • --
  • Ronald Evan Holtz
  • Executive Vice President, Administration
  • --
  • Dr. Richard H. Douglas, PhD
  • Chairman of the Board
  • 115.94K
  • Rekha Hemrajani
  • Independent Director
  • 89.94K
  • John Joseph Johnston
  • Independent Director
  • 85.94K
  • William Wade Brooke
  • Independent Director
  • 101.94K
  • Stanley Charles Erck
  • Independent Director
  • 86.94K
  • Dr. Yasir B. Al-Wakeel
  • Independent Director
  • 85.94K
  • Patrick J Balthrop Sr
  • Independent Director
  • 3.75K
  • Arthur Michael Mandell
  • Independent Director
  • 95.94K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg